SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2026)
SAB Biotherapeutics' (SABS) quarterly Exchange Rate Effect came in at $14729.0 in Q1 2026, down 65.34% YoY from $42500.0 in Q1 2025, and up 103.7% on a QoQ basis from -$397861.0 in Q4 2025.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2026) Analysis & Trends
SAB Biotherapeutics (SABS) has 3 years of Exchange Rate Effect data on file, last reported at $14729.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 65.34% year-over-year to $14729.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$241268.0 (down 41.57% YoY) and the FY2025 annual result came in at -$213497.0, up 11.48% from the prior year.
- Exchange Rate Effect improved to $14729.0 in Q1 2026, from -$397861.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $179401.0 in Q2 2025 to a low of -$397861.0 in Q4 2025.
- A 3-year average of -$48885.1 and a median of $14729.0 in 2026 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 534.31% in 2025, down 178.96% in 2025.
- Tracing SABS's Exchange Rate Effect over 3 years: stood at -$288748.0 in 2024, then plunged by 37.79% to -$397861.0 in 2025, then soared by 103.7% to $14729.0 in 2026.
- The last three Exchange Rate Effect figures came in at $14729.0 (Q1 2026), -$397861.0 (Q4 2025), and -$37537.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 10 | SAB Biotherapeutics | 296.68 Mn | 296.68 Mn | - | 107,271.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107,271.00 |
| Mar 31, 2026 | 14,729.00 |
| Dec 31, 2025 | -397,861.00 |
| Sep 30, 2025 | -37,636.00 |
| Jun 30, 2025 | 179,500.00 |
| Mar 31, 2025 | 42,500.00 |
| Dec 31, 2024 | -288,748.00 |
| Sep 30, 2024 | 47,537.00 |
| Jun 30, 2024 | 28,283.00 |
| Mar 31, 2024 | -28,270.00 |